Worth Financial Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Buy
+1,870
New +$640K 0.28% 82
2026
Q1
Sell
-1,844
Closed -$604K 52
2025
Q4
$604K Buy
1,844
+552
+43% +$175K 0.29% 81
2025
Q3
$365K Buy
1,292
+17
+1% +$4.93K 0.2% 107
2025
Q2
$356K Sell
1,275
-7
-0.5% -$1.98K 0.22% 102
2025
Q1
$399K Sell
1,282
-1,957
-60% -$578K 0.25% 97
2024
Q4
$844K Sell
3,239
-137
-4% -$40.6K 0.52% 48
2024
Q3
$1.09M Buy
3,376
+96
+3% +$31.4K 0.64% 35
2024
Q2
$1.02M Buy
3,280
+197
+6% +$57.9K 0.67% 35
2024
Q1
$877K Buy
3,083
+34
+1% +$9.95K 0.61% 43
2023
Q4
$878K Sell
3,049
-40
-1% -$10.9K 0.7% 36
2023
Q3
$830K Buy
3,089
+626
+25% +$156K 0.75% 33
2023
Q2
$547K Buy
2,463
+1,267
+106% +$294K 0.51% 56
2023
Q1
$289K Sell
1,196
-102
-8% -$25K 0.28% 89
2022
Q4
$341K Buy
+1,298
New +$348K 0.4% 68

Other funds holding AMGN

Worth Financial Advisory Group's AMGN Position: Q2 2026 in Review

Worth Financial Advisory Group opened a new position in Amgen (AMGN) in Q2 2026: 1,870 shares worth $677K. The stake represents 0.28% of the portfolio and ranks #82 among its holdings. This is a return to the name: Worth Financial Advisory Group previously reported a position in AMGN as recently as Q4 2025.

Worth Financial Advisory Group first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.09M in Q3 2024. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Worth Financial Advisory Group held 1,870 shares of Amgen worth $677K as of Q2 2026.
  • Amgen was a new Worth Financial Advisory Group position in Q2 2026.
  • Amgen made up 0.28% of Worth Financial Advisory Group's portfolio in Q2 2026, its #82 holding.
  • Worth Financial Advisory Group first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Worth Financial Advisory Group's Amgen position peaked at $1.09M in Q3 2024.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Worth Financial Advisory Group's 13F filing for Q2 2026, filed 31 Jul 2026.